hVIVO Investor Relations Material
Latest events
H1 2025 TU
hVIVO
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from hVIVO plc
Access all reports
hVIVO plc is a contract research organization (CRO) based in the United Kingdom, specializing in the testing of vaccines and antiviral treatments using human challenge clinical trials. The company is a global leader in this niche field, focusing on infectious and respiratory diseases. hVIVO works with major pharmaceutical companies, providing early clinical development services and testing products in areas like RSV, influenza, COVID-19, and other respiratory conditions. The company is headquartered in London, UK, and its shares are listed on the LSE.
Key slides for hVIVO plc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
HVO
Country
🇬🇧 United Kingdom